NCT02307864 - Study to Evaluate the Effects of Tramadol Hydrochloride on Cardiac Repolarization in Healthy Participants | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 4, 2014

Primary Completion Date

August 22, 2015

Study Completion Date

August 27, 2015

Conditions

Healthy

Interventions

DRUG

Tramadol HCl

Tramadol HCl 50 mg immediate release (IR) tablet administered orally.

DRUG

Moxifloxacin 400 mg

Moxifloxacin 400 mg tablet administered orally.

DRUG

Tramadol HCl Placebo

Placebo matched to tramadol HCl IR tablet administered orally.

DRUG

Moxifloxacin Placebo

Placebo matched to Moxifloxacin 400 mg tablet administered orally.

Trial Locations (1)

Overland Park